McKesson Corp. closed 6.64% below its 52-week high of $637.51, which the company achieved on August 2nd.

The stock's fall snapped a two-day winning streak.

Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

$50,000 of MCKESSON CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "General Medicare/Medicaid Issues.

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

Park Avenue Securities LLC lessened its position in McKesson Co. (NYSE:MCK – Free Report) by 2.5% during the fourth quarter, according to the company in its most recent filing with the Securities & ...

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Brookstone Capital Management boosted its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 42.8% in the fourth ...

META_DESC_INVESTMENT_IDEA ...